Search research articles
Contact Us
Filters
Showing results (101-110 of 1,272) with videos related to
Page
of 128
Sort By:
Journal of the National Cancer Institute
|
August 2, 1995
Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example
S G Baker, L S Freedman
Hematology/Oncology Clinics of North America
|
June 1, 1993
Developments in purging in autotransplantation
A S Freedman, L M Nadler
American Journal of Public Health
|
June 1, 1989
The relation of body fat distribution, as assessed by six girth measurements, to diabetes mellitus in women
D S Freedman, A A Rimm
Statistics in Medicine
|
July 15, 1994
Early stopping of prevention trials when multiple outcomes are of interest: a discussion
S B Green, L S Freedman
Hematology/Oncology Clinics of North America
|
October 1, 1991
Immunologic markers in non-Hodgkin's lymphoma
A S Freedman, L M Nadler
International Reviews of Immunology
|
January 1, 1991
T cell responses to ovarian tumor vaccines: identification and significance for future immunotherapy
C G Ioannides, R S Freedman
Nephrology News & Issues
|
October 13, 2015
iPS cell technology: Future impact on renal care
Benjamin S Freedman, Theodore I Steinman
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
February 1, 1989
Vascular headache: a presenting symptom of multiple sclerosis
M S Freedman, T A Gray
The American Journal of Clinical Nutrition
|
March 4, 2015
Are the recent secular increases in the waist circumference of adults independent of changes in BMI?
David S Freedman, Earl S Ford
The Lancet. Neurology
|
June 21, 2011
Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases
Antonio Uccelli, Alice Laroni, Mark S Freedman
Page
of 128
Search research articles
Search
Showing results (101-110 of 1,272) with videos related to
Sort By:
Page
of 128
Journal of the National Cancer Institute
|
August 2, 1995
Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example
S G Baker, L S Freedman
Hematology/Oncology Clinics of North America
|
June 1, 1993
Developments in purging in autotransplantation
A S Freedman, L M Nadler
American Journal of Public Health
|
June 1, 1989
The relation of body fat distribution, as assessed by six girth measurements, to diabetes mellitus in women
D S Freedman, A A Rimm
Statistics in Medicine
|
July 15, 1994
Early stopping of prevention trials when multiple outcomes are of interest: a discussion
S B Green, L S Freedman
Hematology/Oncology Clinics of North America
|
October 1, 1991
Immunologic markers in non-Hodgkin's lymphoma
A S Freedman, L M Nadler
International Reviews of Immunology
|
January 1, 1991
T cell responses to ovarian tumor vaccines: identification and significance for future immunotherapy
C G Ioannides, R S Freedman
Nephrology News & Issues
|
October 13, 2015
iPS cell technology: Future impact on renal care
Benjamin S Freedman, Theodore I Steinman
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
February 1, 1989
Vascular headache: a presenting symptom of multiple sclerosis
M S Freedman, T A Gray
The American Journal of Clinical Nutrition
|
March 4, 2015
Are the recent secular increases in the waist circumference of adults independent of changes in BMI?
David S Freedman, Earl S Ford
The Lancet. Neurology
|
June 21, 2011
Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases
Antonio Uccelli, Alice Laroni, Mark S Freedman
Page
of 128